| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 5 |
| NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: E9AYI9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 15 | 19 | PF00656 | 0.520 |
| CLV_C14_Caspase3-7 | 87 | 91 | PF00656 | 0.532 |
| CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.575 |
| CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.580 |
| DOC_CYCLIN_yCln2_LP_2 | 71 | 77 | PF00134 | 0.715 |
| DOC_MAPK_MEF2A_6 | 72 | 81 | PF00069 | 0.569 |
| DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.741 |
| DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.630 |
| DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.580 |
| LIG_14-3-3_CanoR_1 | 12 | 17 | PF00244 | 0.515 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.502 |
| LIG_FHA_2 | 47 | 53 | PF00498 | 0.708 |
| LIG_IRF3_LxIS_1 | 75 | 82 | PF10401 | 0.501 |
| LIG_LIR_Gen_1 | 25 | 33 | PF02991 | 0.570 |
| LIG_LIR_Gen_1 | 65 | 76 | PF02991 | 0.575 |
| LIG_LIR_Gen_1 | 91 | 101 | PF02991 | 0.560 |
| LIG_LIR_Nem_3 | 25 | 30 | PF02991 | 0.685 |
| LIG_LIR_Nem_3 | 65 | 71 | PF02991 | 0.600 |
| LIG_LIR_Nem_3 | 82 | 86 | PF02991 | 0.368 |
| LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.479 |
| LIG_MYND_1 | 42 | 46 | PF01753 | 0.655 |
| LIG_Pex14_2 | 84 | 88 | PF04695 | 0.633 |
| LIG_SH2_CRK | 27 | 31 | PF00017 | 0.564 |
| LIG_SH2_CRK | 94 | 98 | PF00017 | 0.566 |
| LIG_SH2_NCK_1 | 94 | 98 | PF00017 | 0.517 |
| LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.494 |
| LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.519 |
| LIG_SH3_3 | 35 | 41 | PF00018 | 0.622 |
| LIG_SH3_3 | 70 | 76 | PF00018 | 0.676 |
| LIG_TYR_ITIM | 81 | 86 | PF00017 | 0.477 |
| MOD_CDK_SPxK_1 | 34 | 40 | PF00069 | 0.584 |
| MOD_CK1_1 | 105 | 111 | PF00069 | 0.603 |
| MOD_CK1_1 | 2 | 8 | PF00069 | 0.543 |
| MOD_CK1_1 | 63 | 69 | PF00069 | 0.642 |
| MOD_CK1_1 | 82 | 88 | PF00069 | 0.326 |
| MOD_CK2_1 | 46 | 52 | PF00069 | 0.717 |
| MOD_CK2_1 | 63 | 69 | PF00069 | 0.497 |
| MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.536 |
| MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.631 |
| MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.532 |
| MOD_GSK3_1 | 12 | 19 | PF00069 | 0.585 |
| MOD_N-GLC_1 | 53 | 58 | PF02516 | 0.662 |
| MOD_NEK2_1 | 79 | 84 | PF00069 | 0.533 |
| MOD_PIKK_1 | 102 | 108 | PF00454 | 0.607 |
| MOD_PK_1 | 12 | 18 | PF00069 | 0.516 |
| MOD_PKA_2 | 88 | 94 | PF00069 | 0.536 |
| MOD_Plk_1 | 100 | 106 | PF00069 | 0.590 |
| MOD_Plk_4 | 12 | 18 | PF00069 | 0.589 |
| MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.584 |
| TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.560 |
| TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.596 |
| TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.375 |
| TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.478 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A3Q8ICY6 | Leishmania donovani | 96% | 100% |
| A4HF53 | Leishmania braziliensis | 69% | 100% |
| A4I2D7 | Leishmania infantum | 96% | 100% |
| Q4Q8Y3 | Leishmania major | 95% | 100% |